Announcements Trials
Browse Landscape

Phase

Phase 4 4

Status

Recruiting 2Completed 2

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 3Other 1Genitourinary 1

Conditions

Prostatic Neoplasms 1Kidney Neoplasms 1Constipation 1Colorectal Neoplasms 1Colorectal Cancer Screening 1Colonic Neoplasms 1

Interventions

Dexamethasone 56Metformin 50Cyclophosphamide 47Saline Solution 39Cytarabine 37Cisplatin 36Zoledronic Acid 34Letrozole 34Carboplatin 33Sodium Chloride 32Bupivacaine 31Docetaxel 30Bevacizumab 30Vincristine 29Methotrexate 29Fluorouracil 28Propofol 27Capecitabine 27Fentanyl 26Doxorubicin 26Rituximab 25Drug Therapy 25Dexmedetomidine 25Prednisone 23Paclitaxel 23Oxaliplatin 21Morphine 21Gemcitabine 21Radiotherapy 19Prednisolone 19

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 4 × Interventional × polyethylene glycol 3350 × Clear all
NCT07215000 2025-10-09

COOP SIT

Morehouse School of Medicine

Phase 4 Recruiting
300 enrolled
Gastrointestinal

Colorectal Cancer Screening

NCT05805436 2025-05-30

Preop Laxatives in Robotic Urologic Surgery

University of Iowa

Phase 4 Recruiting
240 enrolled
GenitourinaryOther

Constipation, Kidney Neoplasms, Prostatic Neoplasms

NCT01170754 2017-09-13

Miralax (PEG 3350) vs. Golytely as Bowel Preparation for Screening Colonoscopy

Temple University

Phase 4 Completed
136 enrolled 17 charts
Gastrointestinal

Colonic Neoplasms

NCT00626054 2016-04-13

PEG

Rabin Medical Center

Phase 4 Completed
400 enrolled
Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡